Skip to main content

Table 4 Carriage of specific pneumococcal subtypes in children with asthma, by pneumococcal vaccination status

From: Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine

 

Vaccinated with PCV7, n (%)

Not vaccinated with PCV7, n (%)

Crude OR (95 % CI)

OR (95 % CI)a

Total carriers

93

99

  

Carriers of serotypes not included in PCV13

4 (4.3)

6 (6.0)

0.84 (0.23–3.07)

0.97 (0.25–3.77)

Carriers of PCV13 serotypes

 1

32 (34.4)

29 (29.2)

1.40 (0.80–2.47)

1.23 (0.69–2.21)

 2

41 (44.1)

28 (28.2)

1.86 (1.08–3.21)

1.64 (0.93–2.89)

 ≥3

16 (17.2)

36 (36.6)

0.57 (0.30–1.08)

0.46 (0.23–0.91)

Carriers of different PCV13 serotypes

 Serotype 1

1 (1.0)

2 (2.0)

0.58 (0.05–6.47)

0.56 (0.05–6.40)

 Serotype 3

12 (13.0)

11 (11.1)

1.29 (0.56–3.00)

1.18 (0.50–2.80)

 Serotype 4

26 (28.0)

39 (39.4)

0.75 (0.43–1.28)

0.62 (0.36–1.09)

 Serotype 5

15 (16.1)

23 (23.2)

0.74 (0.38–1.47)

0.68 (0.33–1.38)

 Serotype 6A

5 (5.4)

6 (6.1)

0.97 (0.29–3.24)

0.65 (0.18–2.40)

 Serotype 6B

0 (0.0)

3 (3.0)

NE

NE

 Serotype 7 F

2 (2.1)

4(4.0)

0.58 (0.10–3.20)

0.60 (0.10–3.49)

 Serotype 9 V

18 (19.3)

22 (22.1)

0.95 (0.49–1.83)

0.95 (0.48–1.87)

 Serotype 14

0 (0.0)

1 (1.0)

NE

NE

 Serotype 18C

0 (0.0)

0 (0.0)

NE

NE

 Serotype 19A

3 (3.2)

7 (7.1)

0.49 (0.13–1.94)

0.43 (0.11–1.77)

 Serotype 19 F

83 (89.2)

84 (84.9)

1.27 (0.86–1.88)

1.13 (0.75–1.70)

 Serotype 23 F

2 (2.1)

2 (2.0)

1.17 (0.16–8.40)

0.83 (0.11–6.26)

  1. Reference category is non-carrier of corresponding serotypes
  2. 95 % CI 95 % confidence interval; NE not estimable; OR odds ratio; PCV7 7-valent pneumococcal conjugate vaccine; PCV13 13-valent pneumococcal conjugate vaccine
  3. aORs adjusted for age (as a continuous term), gender, ethnicity, number of sibling, and parental smoking